ROSSARI BIOTECH LIMITED
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it offers poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 1997 and is based in Mumbai, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockRule-based from financial data. Not advice.
Historically, Apr has averaged the highest return (+13.2%); Feb the lowest (-12.6%).
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.8%Negative MonthJan 2026: -2.75% | -11.6%Negative MonthFeb 2026: -11.65% | -24.1%Negative MonthMar 2026: -24.07% | +26.6%Positive MonthApr 2026: +26.55% | +10.0%Positive MonthMay 2026: +10.05% | -0.3%Neutral MonthJun 2026: -0.33% | -4.0%*Negative MonthJul 2026: -4.00% | β | β | β | β | β |
| 2025 | -6.2%Negative MonthJan 2025: -6.21% | -17.6%Negative MonthFeb 2025: -17.63% | +1.0%Neutral MonthMar 2025: +0.96% | +9.2%Positive MonthApr 2025: +9.21% | +0.5%Neutral MonthMay 2025: +0.48% | +4.0%Positive MonthJun 2025: +4.02% | +1.8%Neutral MonthJul 2025: +1.77% | -11.9%Negative MonthAug 2025: -11.90% | -0.0%Neutral MonthSep 2025: -0.02% | +3.7%Positive MonthOct 2025: +3.66% | -6.2%Negative MonthNov 2025: -6.20% | -3.5%Negative MonthDec 2025: -3.51% |
| 2024 | -0.7%Neutral MonthJan 2024: -0.66% | -6.3%Negative MonthFeb 2024: -6.28% | -9.4%Negative MonthMar 2024: -9.37% | +11.0%Positive MonthApr 2024: +10.96% | -7.9%Negative MonthMay 2024: -7.94% | +22.0%Positive MonthJun 2024: +22.03% | -0.8%Neutral MonthJul 2024: -0.82% | +5.6%Positive MonthAug 2024: +5.62% | +3.0%Positive MonthSep 2024: +3.05% | -10.8%Negative MonthOct 2024: -10.76% | +0.8%Neutral MonthNov 2024: +0.80% | -5.1%Negative MonthDec 2024: -5.13% |
| 2023 | -5.6%Negative MonthJan 2023: -5.58% | -9.4%Negative MonthFeb 2023: -9.45% | -4.3%Negative MonthMar 2023: -4.28% | +15.6%Positive MonthApr 2023: +15.63% | +6.4%Positive MonthMay 2023: +6.45% | +18.6%Positive MonthJun 2023: +18.62% | +0.7%Neutral MonthJul 2023: +0.72% | -1.1%Neutral MonthAug 2023: -1.06% | -5.9%Negative MonthSep 2023: -5.94% | -9.2%Negative MonthOct 2023: -9.21% | -2.4%Negative MonthNov 2023: -2.45% | +10.7%Positive MonthDec 2023: +10.75% |
| 2022 | -6.9%Negative MonthJan 2022: -6.86% | -17.9%Negative MonthFeb 2022: -17.85% | -7.0%Negative MonthMar 2022: -7.04% | +3.8%Positive MonthApr 2022: +3.83% | -7.8%Negative MonthMay 2022: -7.84% | -0.2%Neutral MonthJun 2022: -0.25% | +3.2%Positive MonthJul 2022: +3.23% | +9.0%Positive MonthAug 2022: +9.02% | -1.4%Neutral MonthSep 2022: -1.37% | -7.9%Negative MonthOct 2022: -7.87% | -11.5%Negative MonthNov 2022: -11.51% | -7.8%Negative MonthDec 2022: -7.81% |
| 2021 | β | β | β | β | β | -3.0%Negative MonthJun 2021: -2.97% | +3.8%Positive MonthJul 2021: +3.77% | +13.5%Positive MonthAug 2021: +13.54% | +3.4%Positive MonthSep 2021: +3.36% | -2.6%Negative MonthOct 2021: -2.57% | -8.8%Negative MonthNov 2021: -8.78% | -0.4%Neutral MonthDec 2021: -0.40% |
| AvgΒ±SD |
Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.
This aggregates every month by calendar position β all Januaries together, all Februaries together, and so on β to show whether a given month has leaned positive or negative historically. βSimpleβ counts each month as +1 or β1. βWeightedβ gives larger moves more influence: +2 above +10%, β2 below β10%. With only 6 years of history for this asset, each monthβs score reflects a small number of observations β read it as a historical tendency, not a reliable seasonal pattern.
This tracks a running tally across the assetβs full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.
Year-to-date return is calculated by dividing each dayβs closing price by the price on January 1st of that year (or the assetβs first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in βAverage fromβ, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ1.43 K Cr | β | βΉ115.00 Cr | β | β | 10.7% | 19.0% | 15.0% |
| Mar 2024 | βΉ1.20 K Cr | β | βΉ100.00 Cr | β | β | 10.4% | 23.4% | 40.8% |
| Mar 2023 | βΉ975.00 Cr | β | βΉ71.00 Cr | β | β | 8.3% | -9.1% | -10.1% |
| Mar 2022 | βΉ1.07 K Cr | β | βΉ79.00 Cr | β | β | 10.1% | 55.5% | 0.0% |
| Mar 2021 | βΉ690.00 Cr | β | βΉ79.00 Cr | β | β | 19.6% | 15.0% | 19.7% |
| Mar 2020 | βΉ600.00 Cr | β | βΉ66.00 Cr | β | β | 23.3% | 16.3% | 43.5% |
| Mar 2019 | βΉ516.00 Cr | β | βΉ46.00 Cr | β | β | 38.3% | 76.7% | 58.6% |
| Mar 2018 | βΉ292.00 Cr | β | βΉ29.00 Cr | β | β | 32.6% | 25.3% | 81.3% |
| Mar 2017 | βΉ233.00 Cr | β | βΉ16.00 Cr | β | β | 26.7% | 30.9% | 433.3% |
| Mar 2016 | βΉ178.00 Cr | β | βΉ3.00 Cr | β | β | 6.7% | 45.9% | -40.0% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | Mar 2011 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Net Sales | 122 | 178 | 233 | 292 | 516 | 600 | 690 | 1,073 | 975 | 1,203 | 1,432 | 1,580 |
| Total Expenses | 108 | 166 | 209 | 247 | 438 | 495 | 569 | 950 | 853 | 1,042 | 1,245 | 1,384 |
| EBIT / Operating Profit | 13 | 12 | 24 | 45 | 78 | 105 | 121 | 123 | 123 | 161 | 186 | 197 |
| OPM % | 11% | 7% | 10% | 15% | 15% | 18% | 18% | 11% | 13% | 13% | 13% | 12% |
| Other Income | 0 | 0 | 1 | 1 | 1 | 4 | 10 | 13 | 4 | 7 | 6 | 7 |
| Finance Costs | 3 | 3 | 2 | 1 | 3 | 4 | 3 | 3 | 5 | 10 | 10 | 11 |
| Depreciation & Amortisation | 5 | 4 | 4 | 5 | 12 | 17 | 22 | 26 | 26 | 24 | 28 | 30 |
| Profit Before Tax | 6 | 5 | 19 | 39 | 63 | 88 | 106 | 107 | 96 | 134 | 155 | 163 |
| Tax % | 11% | 29% | 17% | 27% | 28% | 26% | 25% | 26% | 25% | 26% | 26% | - |
| Net Profit / PAT | 5 | 3 | 16 | 29 | 46 | 66 | 79 | 79 | 71 | 100 | 115 | 120 |
| EPS (βΉ) | 11.59 | 7.77 | 35.43 | 65.73 | 104.07 | 12.91 | 15.23 | 14.43 | 12.94 | 18.04 | 20.72 | 21.75 |
| Dividend Payout % | 1% | 0% | 1% | 0% | 0% | 4% | 3% | 3% | 4% | 3% | 2% | - |
Peer Comparison
Technology sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| ROSSARI BIOTECH LIMITEDthis co. | βΉ3.02 K Cr | βΉ1.43 K Cr | 25.00 | 2.67 | 17.69 | 19.0% |
| Bharti Airtel Ltd. | βΉ12.19 L Cr | βΉ1.09 L Cr | 50.40 | 8.31 | 27.19 | 15.8% |
| Tata Consultancy Services Ltd. | βΉ11.84 L Cr | βΉ2.15 L Cr | 24.20 | 13.91 | 18.91 | 6.2% |
| Infosys Ltd | βΉ6.48 L Cr | βΉ1.37 L Cr | 24.20 | 7.17 | 16.31 | 5.9% |
| HCL Technologies Ltd | βΉ4.52 L Cr | βΉ51.10 K Cr | 36.80 | 14.48 | β | 6.2% |
| Bharat Electronics Ltd. | βΉ3.02 L Cr | βΉ23.66 K Cr | 53.30 | 14.23 | 51.32 | 17.3% |
| Wipro Ltd. | βΉ2.77 L Cr | βΉ67.29 K Cr | 23.00 | 4.29 | 18.85 | 0.8% |
| Industry Average | β | βΉ10.05 K Cr | 69.99 | 8.58 | 66.75 | 22.0% |
